510(k) Report

510(k) · Cleared

Recalled · Class II · 2025

Omni Legend

K221932510(k) TraditionalCleared Sep 2, 202263-day reviewClass II21 CFR 892.1200Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

GE Healthcare · KPS System, Tomography, Computed, Emission

Cleared on Sep 2, 2022 as substantially equivalent to K211846 (Ge Medical Systems, LLC, 2021) after a 63-day review. Its family tree reaches back 9 generations to 2001. 2 later devices descend from it. It has been recalled once.

Decided
Sep 2, 2022
Review
63 days
Class
Class II
Product code
KPS
Recalls
1
Predicates
1

Its longest line of descent runs back 9 generations to K010641 (2001). 11 ancestors in all. 2 later devices descend from it, 2 citing it directly.

  1. Root · 9 generations backK010641 GE CT-Pet SystemGe Medical Systems, Inc. · 2001
  2. 5 generations between
  3. 3 generations backK133657 Discovery Pet/CT 710Ge Medical Systems, LLC · 2014 · Recalled
  4. 2 generations backK161574 Discovery MIGe Medical Systems, LLC · 2016 · Recalled
  5. 1 generation backK211846 Discovery MI Gen2Ge Medical Systems, LLC · 2021
  6. This deviceK221932 Omni LegendGE Healthcare · 2022
  7. Descendant · cites it directly · 0 of its ownK241665 Omni LegendGe Medical Systems Israel, Functional Imaging · 2024 · Recalled
  8. Descendant · cites it directly · 0 of its ownK223212 Precision DLGE Healthcare · 2023
Show all 9 generations
  1. Root · 9 generations backK010641 GE CT-Pet SystemGe Medical Systems, Inc. · 2001
  2. 8 generations backK023988 GE Discovery LS SystemGE Medical Systems · 2003 · Recalled
  3. 7 generations backK040172 Modification to GE Discovery LS SystemGE Medical Systems · 2004 · Recalled
  4. 6 generations backK041543 GE Discovery STGE Healthcare · 2004 · Recalled
  5. 5 generations backK050559 GE Discovery VCT SystemGE Medical Systems · 2005 · Recalled
  6. 4 generations backK081496 Optima Pet/CT 560Ge Medical Systems, LLC · 2008 · Recalled
  7. 3 generations backK133657 Discovery Pet/CT 710Ge Medical Systems, LLC · 2014 · Recalled
  8. 2 generations backK161574 Discovery MIGe Medical Systems, LLC · 2016 · Recalled
  9. 1 generation backK211846 Discovery MI Gen2Ge Medical Systems, LLC · 2021
  10. This deviceK221932 Omni LegendGE Healthcare · 2022

Most influential descendants

Showing 2 of 2 · See all
  • K241665Omni LegendGe Medical Systems Israel, Functional Imaging · 2024 · cites it directly0descendants
  • K223212Precision DLGE Healthcare · 2023 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K010641GE CT-Pet SystemGe Medical Systems, Inc.2001—
−8K023988GE Discovery LS SystemGE Medical Systems20031
−7K040172Modification to GE Discovery LS SystemGE Medical Systems20045
−6K041543GE Discovery STGE Healthcare20041
−5K050559GE Discovery VCT SystemGE Medical Systems20051
−4K081496Optima Pet/CT 560Ge Medical Systems, LLC20087
−3K133657Discovery Pet/CT 710Ge Medical Systems, LLC20144
−2K161574Discovery MIGe Medical Systems, LLC20163
−1K211846Discovery MI Gen2Ge Medical Systems, LLC2021—
0 (this device)K221932Omni LegendGE Healthcare2022—
+1K241665Omni LegendGe Medical Systems Israel, Functional Imaging20241
+1K223212Precision DLGE Healthcare2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
202410
FIG. 1 — Lineage of K221932, 2001–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPS device

  1. #1 K253564 uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI…score 18.6 · 17 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K211846Discovery MI Gen2
Summary page 5
…JAK Predicate Device Information Device Name Discovery MI Gen2 Manufacturer GE Medical System, LLC. 510(k) number K211846 Regulation number 21CFR 892.1200 and 21CFR 892.1750 Product Code 90 KPS and 90 JAK Reference Devic…
Ge Medical Systems, LLC2021—
†K161574Discovery MIGe Medical Systems, LLC20163
†K141477Discovery IQGe Medical Systems, LLC20143

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K241665Omni LegendGe Medical Systems Israel, Functional Imaging20240
K223212Precision DLGE Healthcare20230

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 24, 2025Class IIZ-1112-2026Software designThere is a potential intermittent issue on certain Omni Legend systems that can result in a streaking artifact in the PET clinical scan images. This streaking artifact is most easily identified in transaxial slices on the acquisition…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 4 companies; a new generation was cleared every 1.9 years on median.
  • 8 of the 11 ancestors have a recall of any class.
  • Of its descendants, K241665 (Ge Medical Systems Israel, Functional Imaging, 2024) has gone furthest, with 0 descendants of its own.

How does its category compare?

All KPS devices

KPS System, Tomography, Computed, Emission: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · KPS

12in 2025

2007: 82008: 172009: 92010: 32011: 72012: 62013: 112014: 112015: 32016: 112017: 112018: 132019: 32020: 122021: 152022: 52023: 122024: 112025: 122026 (partial year): 6
2007high 17 (2008) · low 3 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPS

65in 2025

2007: 38 days median2008: 25 days median2009: 42 days median2010: 91 days median2011: 28 days median2012: 94 days median2013: 84 days median2014: 92 days median2015: 112 days median2016: 65 days median2017: 104 days median2018: 59 days median2019: 60 days median2020: 72 days median2021: 66 days median2022: 60 days median2023: 63 days median2024: 59 days median2025: 65 days median2026 (partial year): 67 days median
2007high 112 (2015) · low 25 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPS

16in 2025

2007: 222008: 162009: 142010: 42011: 342012: 132013: 132014: 182015: 52016: 162017: 112018: 12, 3 Class I2019: 5, 5 Class I2020: 82021: 42022: 8, 6 Class I2023: 6, 3 Class I2024: 152025: 162026 (partial year): 6
2007high 34 (2011) · low 4 (2010)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · KPS

36in 2025

2007: 382008: 112009: 152010: 442011: 562012: 342013: 2402014: 332015: 242016: 102017: 312018: 262019: 1052020: 222021: 102022: 152023: 222024: 232025: 36
2007high 240 (2013) · low 10 (2016)2025

MAUDE reports naming product code KPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078382238
200817251611
20099421415
2010391444
20117283456
20126941334
2013118413240
201411921833
20153112524
201611651610
2017111041131
2018135912 (3)26
20193605 (5)105
20201272822
20211566410
20225608 (6)15
202312636 (3)22
202411591523
202512651636
20266676—

What is it indicated for?

The GE Omni Legend is a PET/CT system for producing attenuation corrected PET images. It is intended to be used by qualified health care professionals for imaging the distribution and localization of any positron-emitting radiopharmaceutical in a patient, for the assessment of metabolic (molecular) and physiologic function in patients, with a wide range of sizes and extent of disease, of all ages. Omni Legend is intended to image the whole body, head…

Read the full statement (301 words)

The GE Omni Legend is a PET/CT system for producing attenuation corrected PET images. It is intended to be used by qualified health care professionals for imaging the distribution and localization of any positron-emitting radiopharmaceutical in a patient, for the assessment of metabolic (molecular) and physiologic function in patients, with a wide range of sizes and extent of disease, of all ages.

Omni Legend is intended to image the whole body, head, heart, brain, lung, breast, bone, the gastrointestinal and lymphatic systems, and other organs. The images produced by the system may be used by physicians to aid in radiotherapy treatment planning, therapy guidance and monitoring, and in interventional radiology procedures. The images may also be used for precise functional and anatomical mapping (localization, registration, and fusion).

When used with radiopharmaceuticals approved by the regulatory authority in the country of use, the raw and image data is an aid in; detection, localization, evaluation, diagnosis, staging, restaging, monitoring, and/or follow up, of abnormalities, lesions, tumors, inflammation, infection, organ function, disorders, and/or disease, such as, but not limited to, those in oncology, cardiology, and neurology.

Examples of which are:

Cardiology:

• Cardiovascular disease

• Myocardial perfusion

• Myocardial viability

• Cardiac inflammation

• Coronary artery disease

Neurology:

• Epilepsy

• Dementia, such as Alzheimer’s disease, Lewy body dementia, Parkinson’s disease with dementia, and frontotemporal dementia

• Movement disorders, such as Parkinson’s and Huntington’s disease

• Tumors

• Inflammation

• Cerebrovascular disease such as acute stroke, chronic and acute ischemia

• Traumatic Brain Injury (TBI)

Oncology/Cancer:

• Non-Small Cell Lung Cancer

• Small Cell Lung Cancer

• Breast Cancer

• Prostate Cancer

• Hodgkin disease

• Non-Hodgkin lymphoma

• Colorectal Cancer

• Melanoma

Omni Legend is also intended for stand-alone, diagnostic CT imaging in accordance with the stand-alone CT system’s cleared indications for use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K221932: Omni Legend.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K221932

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026